Filing Flows › Amgen (AMGN) › Operating margin
Amgen (AMGN) operating margin by quarter
Amgen's operating margin was 35.8% in Q3 2026 (third quarter 2026), +0.8 pts from Q2 2026. Over the last 7 quarters it ranged from 14.5% (Q1 2025) to 35.8% (Q3 2026).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 35.8% | +0.8 pts | +9.4 pts |
| Q2 2026 | 35.0% | +4.0 pts | +6.0 pts |
| Q1 2026 | 30.9% | +3.4 pts | +16.5 pts |
| Q4 2025 | 27.6% | +1.1 pts | — |
| Q3 2025 | 26.4% | -2.5 pts | — |
| Q2 2025 | 28.9% | +14.5 pts | — |
| Q1 2025 | 14.5% | — | — |
Q3 2026 at a glance
Amgen, Q3 2026: revenue $10.4B (+8% year over year), operating margin 35.8%, net earnings $3.9B, operating cash flow $4.2B. The chart follows the revenue to costs, profit and cash.
Questions
What is Amgen's operating margin?
Amgen's operating margin was 35.8% in Q3 2026 (third quarter 2026), +0.8 pts from Q2 2026.
How has Amgen's operating margin changed?
Over the last 7 quarters it ranged from 14.5% (Q1 2025) to 35.8% (Q3 2026).